CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival
- 30 November 2010
- journal article
- Published by Elsevier BV in Journal of Clinical Neuroscience
- Vol. 17 (11), 1381-1385
- https://doi.org/10.1016/j.jocn.2010.03.031
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (F32 CA132489-01A1)
- University of California, San Francisco (F32CA132489-01A1)
This publication has 53 references indexed in Scilit:
- An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiformeMolecular Cancer Therapeutics, 2009
- EGFRvIII‐Targeted Vaccination Therapy of Malignant GliomaBrain Pathology, 2009
- The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patientsExpert Opinion on Biological Therapy, 2009
- The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses1Neuro-Oncology, 2006
- An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme1Neuro-Oncology, 2006
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004
- Cerebral astrocytoma in HIV-infected patientsAIDS, 1995
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI Journal of the National Cancer Institute, 1989
- Inflammatory infiltrates and natural killer cell presence in human brain tumorsCancer, 1988
- Prognostic value of round cell (lymphocyte) infiltration in malignant gliomasSurgical Neurology, 1985